Associate Dean for Veterans Affairs Medical Center
Professor, Department of Medicine
Michael S. Simberkoff, M.D.'s research interests are in the areas of pathogenesis and treatment of bacterial infections, treatment of HIV infection, and the prevention and treatment of opportunistic infections. Dr. Simberkoff was the co-chairman of a VA Cooperative Study which compared early with later zidovudine treatment for HIV-infected patients. He was the chairman of VA Cooperative Study of pneumococcal vaccine efficacy in high-risk patients.
Dr. Simberkoff is currently the co-chairman of a multi-center study designed to determine and develop a model to predict the resources, personnel requirements, and costs for the care of HIV-infected patients. He is also a principal investigator in a CDC-sponsored study of nosocomial and community acquired bacterial infections in HIV-infected patients.
Representative
Associate Dean for Veterans Affairs Medical Center
MD from New York University
Journal of acquired immune deficiency syndromes. JAIDS. 2025 Jan 01; 98(1):72-81
Alcohol, clinical & experimental research. 2023 Sep; 47(9):1783-1797
Contemporary clinical trials. 2023 Aug; 131:107242
Open forum infectious diseases. 2023 Feb 01; 10(<prism:issueIdentifier>2):?-?
Journal of infectious diseases. 2022 Mar 02; 225(5):891-902
Clinical infectious diseases. 2021 12 06; 73(11):e4428-e4432
American journal of infection control. 2021 Nov; 49(11):1369-1375
Infection control & hospital epidemiology. 2021 Aug 05; 1-5